Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,925 | 406 | 99.0% |
| Gift | $36.58 | 3 | 0.5% |
| Education | $32.22 | 5 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| NEUROPACE, INC. | $945.45 | 14 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $820.48 | 64 | $0 (2021) |
| UCB, Inc. | $786.91 | 46 | $0 (2024) |
| Eisai Inc. | $680.87 | 36 | $0 (2023) |
| SK Life Science, Inc. | $457.34 | 31 | $0 (2024) |
| Greenwich Biosciences, Inc. | $440.19 | 31 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $432.32 | 28 | $0 (2021) |
| Supernus Pharmaceuticals, Inc. | $428.01 | 34 | $0 (2021) |
| LivaNova USA, Inc. | $383.19 | 15 | $0 (2022) |
| JAZZ PHARMACEUTICALS INC. | $269.53 | 40 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $475.85 | 15 | NEUROPACE, INC. ($161.52) |
| 2023 | $1,008 | 69 | NEUROPACE, INC. ($264.11) |
| 2022 | $670.17 | 27 | NEUROPACE, INC. ($283.04) |
| 2021 | $645.92 | 50 | Greenwich Biosciences, Inc. ($141.09) |
| 2020 | $641.78 | 34 | Eisai Inc. ($216.97) |
| 2019 | $1,111 | 62 | Greenwich Biosciences, Inc. ($232.61) |
| 2018 | $1,002 | 82 | Sunovion Pharmaceuticals Inc. ($295.83) |
| 2017 | $1,439 | 75 | Eisai Inc. ($277.74) |
All Payment Transactions
414 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/11/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Education | Cash or cash equivalent | $16.72 | General |
| Category: NEUROLOGY | ||||||
| 07/17/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: Neurology | ||||||
| 07/11/2024 | Pyros Pharmaceuticals, Inc. | VIGPODER (Drug) | Food and Beverage | In-kind items and services | $58.26 | General |
| Category: PEDIATRIC NEUROLOGY | ||||||
| 06/25/2024 | Aucta Pharmaceuticals, Inc. | Motpoly XR (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Central Nervous System | ||||||
| 06/06/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $15.21 | General |
| 05/22/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $14.55 | General |
| 05/14/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Neurology | ||||||
| 05/01/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: Neurology | ||||||
| 04/25/2024 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | Food and Beverage | In-kind items and services | $161.52 | General |
| Category: Epilepsy | ||||||
| 04/24/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $16.87 | General |
| 04/19/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Food and Beverage | Cash or cash equivalent | $23.62 | General |
| Category: NEUROLOGY | ||||||
| 04/04/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: Neurology | ||||||
| 03/27/2024 | Aucta Pharmaceuticals, Inc. | Motpoly XR (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: Central Nervous System | ||||||
| 03/26/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $15.18 | General |
| 02/21/2024 | BIOCODEX, INC. | DIACOMIT (Drug) | Food and Beverage | In-kind items and services | $50.61 | General |
| Category: Antiepileptic | ||||||
| 12/18/2023 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $23.36 | General |
| 12/18/2023 | Sumitomo Pharma America, Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: CNS | ||||||
| 12/12/2023 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $8.34 | General |
| Category: NEUROLOGY | ||||||
| 12/12/2023 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $2.54 | General |
| Category: NEUROLOGY | ||||||
| 12/11/2023 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $1.79 | General |
| Category: NEUROLOGY | ||||||
| 12/04/2023 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: EPILEPSY | ||||||
| 12/02/2023 | Medtronic, Inc. | VISUALASE (Device) | Food and Beverage | In-kind items and services | $79.24 | General |
| Category: MRI-guided laser ablation | ||||||
| 12/01/2023 | NEUROPACE, INC. | RNS Neurostimulator Kit (Device) | Food and Beverage | In-kind items and services | $153.19 | General |
| Category: Epilepsy | ||||||
| 11/28/2023 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $10.55 | General |
| Category: NEUROLOGY | ||||||
| 11/28/2023 | JAZZ PHARMACEUTICALS INC. | EPIDIOLEX (Drug) | Food and Beverage | In-kind items and services | $2.81 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 638 | 926 | $1.4M | $138,224 |
| 2022 | 11 | 752 | 1,181 | $1.9M | $170,777 |
| 2021 | 11 | 506 | 794 | $1.2M | $124,329 |
| 2020 | 11 | 403 | 599 | $234,904 | $68,993 |
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2023 | 145 | 269 | $807,000 | $47,088 | 5.8% |
| 95715 | Measurement of brain wave activity with video (veeg), 12-26 hours with intermittent monitoring | Office | 2023 | 15 | 42 | $126,000 | $30,878 | 24.5% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 32 | 33 | $33,000 | $10,694 | 32.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 84 | 156 | $54,600 | $10,484 | 19.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 73 | 74 | $33,300 | $8,046 | 24.2% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Facility | 2023 | 59 | 61 | $91,500 | $6,911 | 7.6% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Office | 2023 | 15 | 42 | $126,000 | $6,787 | 5.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 66 | 90 | $22,500 | $5,699 | 25.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 64 | 73 | $14,600 | $2,826 | 19.4% |
| 95700 | Measurement of brain wave activity (eeg), continuous | Office | 2023 | 15 | 15 | $30,000 | $2,641 | 8.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $8,100 | $2,424 | 29.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 22 | 23 | $6,900 | $2,354 | 34.1% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 30 | 30 | $15,000 | $1,391 | 9.3% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2022 | 227 | 440 | $1.3M | $78,479 | 5.9% |
| 95715 | Measurement of brain wave activity with video (veeg), 12-26 hours with intermittent monitoring | Office | 2022 | 12 | 33 | $99,000 | $27,097 | 27.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 134 | 285 | $99,750 | $17,469 | 17.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 91 | 91 | $40,950 | $10,561 | 25.8% |
| 95718 | Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | Facility | 2022 | 76 | 78 | $117,000 | $9,024 | 7.7% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2022 | 23 | 24 | $24,000 | $7,829 | 32.6% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Office | 2022 | 12 | 33 | $99,000 | $6,059 | 6.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 55 | 68 | $17,000 | $4,547 | 26.7% |
| 95700 | Measurement of brain wave activity (eeg), continuous | Office | 2022 | 12 | 12 | $24,000 | $2,465 | 10.3% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 47 | 47 | $23,500 | $2,366 | 10.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 37 | 42 | $8,400 | $1,727 | 20.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 16 | $4,800 | $1,596 | 33.2% |
About Dr. Enrique Feoli, M.D
Dr. Enrique Feoli, M.D is a Neurology healthcare provider based in Bangor, Maine. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/19/2006. The National Provider Identifier (NPI) number assigned to this provider is 1629097852.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Enrique Feoli, M.D has received a total of $6,994 in payments from pharmaceutical and medical device companies, with $475.85 received in 2024. These payments were reported across 414 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($6,925).
As a Medicare-enrolled provider, Feoli has provided services to 2,299 Medicare beneficiaries, totaling 3,500 services with total Medicare billing of $502,322. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Bangor, ME
- Active Since 07/19/2006
- Last Updated 07/07/2010
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1629097852
Products in Payments
- APTIOM (Drug) $941.24
- RNS Neurostimulator Kit (Device) $708.67
- Fycompa (Drug) $680.87
- Briviact (Drug) $596.73
- Epidiolex (Drug) $440.19
- AFINITOR (Drug) $400.96
- VNS Therapy (Device) $392.59
- EPIDIOLEX (Drug) $269.53
- RNS System (Device) $236.78
- ACTHAR (Biological) $220.68
- VALTOCO (Drug) $196.80
- OXTELLAR XR (Drug) $139.72
- Vimpat (Drug) $117.22
- ONFI (Drug) $103.69
- TROKENDI XR (Drug) $85.89
- VISUALASE (Device) $79.24
- SYMPAZAN (Drug) $62.40
- VIGPODER (Drug) $58.26
- ROSA (Device) $56.67
- Nayzilam (Drug) $56.22
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Bangor
Markos Poulopoulos, M.d, M.D
Neurology — Payments: $8,705
Carrie Downey, Do, DO
Neurology — Payments: $5,870
Mirna Hajjar
Neurology — Payments: $1,032
Bakhtier Nurmukhamedov, M.d, M.D
Neurology — Payments: $290.15
Tarek Wazzan, M.d, M.D
Neurology — Payments: $200.54
Dr. Karl Sanzenbacher, M.d, M.D
Neurology — Payments: $162.77